Synaptogenix (SNPX) Institutional Ownership $2.37 -0.06 (-2.47%) As of 03:58 PM Eastern Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Synaptogenix (NASDAQ:SNPX)CurrentInstitutional OwnershipPercentage10.34%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$37.63KNumber ofInstitutional Sellers(last 12 months)0 Get SNPX Insider Trade Alerts Want to know when executives and insiders are buying or selling Synaptogenix stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data SNPX Institutional Buying and Selling by Quarter Remove Ads Synaptogenix Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2025Geode Capital Management LLC10,844$39K0.0%N/A0.797% 2/3/2023Cannell & Co.30,000$35K0.0%-60.6%0.413% 1/11/2023Platform Technology Partners25,138$29K0.0%+56.8%0.346% 8/12/2022Ikarian Capital LLC121,191$614K0.1%-20.9%1.772% 5/3/2022Platform Technology Partners16,032$124K0.1%-25.0%0.235% 2/14/2022Diametric Capital LP30,521$260K0.2%-17.2%0.457% 2/7/2022Orion Capital Management LLC4,000$34K0.0%N/A0.060% 2/1/2022Platform Technology Partners21,375$182K0.1%-34.2%0.320% 9/17/2021Virtu Financial LLC14,259$140K0.0%N/A0.232% 8/18/2021Ikarian Capital LLC300,000$2.96M0.2%N/A4.968% 8/17/2021Worth Venture Partners LLC73,909$642K0.2%N/A1.224% 8/17/2021Boothbay Fund Management LLC34,079$336K0.0%N/A0.564% 8/16/2021Diametric Capital LP21,901$216K0.2%N/A0.363% 8/12/2021AIGH Capital Management LLC316,945$2.83M0.5%N/A5.248% 8/10/2021CM Management LLC10,000$99K0.1%N/A0.166% 8/5/2021Platform Technology Partners32,500$320K0.1%N/A0.538% (Data available from 1/1/2016 forward)Remove Ads SNPX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SNPX shares? During the previous two years, the following institutional investors and hedge funds held shares of Synaptogenix shares: Geode Capital Management LLC ($39K).Learn more on SNPX's institutional investors. What percentage of Synaptogenix stock is owned by institutional investors? 10.34% of Synaptogenix stock is owned by institutional investors. Learn more on SNPX's institutional investor holdings. Which institutional investors have been buying Synaptogenix stock? The following institutional investors have purchased Synaptogenix stock in the last 24 months: Geode Capital Management LLC ($10.84K). How much institutional buying is happening at Synaptogenix? Institutional investors have bought a total of 10,844 shares in the last 24 months. This purchase volume represents approximately $37.63K in transactions. Related Companies HCW Biologics Major Shareholders NeuroSense Therapeutics Major Shareholders NextCure Major Shareholders Marker Therapeutics Major Shareholders Incannex Healthcare Major Shareholders Flora Growth Major Shareholders Bright Green Major Shareholders Affimed Major Shareholders TherapeuticsMD Major Shareholders ImmunoPrecise Antibodies Major Shareholders This page (NASDAQ:SNPX) was last updated on 4/2/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Synaptogenix, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Synaptogenix With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.